Tuesday, July 3, 2018

Opportunities with Rising HNW Population Market Outlook: Ken Research


According to the study, HNW Targeting and Retention Strategies Most banks like Credit Suisse, JP Morgan, BNP Paribus Citibank, Morgan Stanley, Deutsche Bank, HSBC provide wealth management services and have a separate business unit consulting of consultants and product specialists to provide wealth assistance to  HNW population. Private wealth management is delivered to high net worth individuals. This includes advice on use of various estates planning vehicles, business succession or stock option planning with the occasional hedging of derivatives for large blocks of stock. Traditionally, the wealthiest retail clients of investment firms demanded a greater level of service, product offering and sales personnel than that received by average clients. With an increase in the number of affluent investors in recent years, there has been an increasing demand for sophisticated financial solutions and expertise throughout the world.
High-net-worth individual (HNWI) is a term used by some segments of the financial services industry to designate persons whose investible assets (such as stocks and bonds) exceed a given amount. Typically, these individuals are defined as holding financial assets (excluding their primary residence) with a value greater than a specified given amount. Initially the HNW population was largely concentrated in the western countries of North America, however recent trends have shown that the population has begun to spread across the globe to cities such as Hong Kong, Dubai, Tokyo, London, Los Angeles to name a few. Furthermore the rise of emerging market over the past decade has triggered the upsurge of HNW population even in the South American and Asia Pacific region. The largest proportion of high net worth individuals in the world can be found in the North American region. Studies reveal that more than half of the HNW population resides in the North America. The global growth in HNI population can be attributed to factors like appreciation in equity and other asset classes and also in markets like commodities and real estate. 
Before selecting a wealth manager, HNW’s look for multitude factors such as experience of the firm, the products and services offered, charges, quality of firm and even employee turnover.
In 2017, China’s top regulators unveiled reforms for the country’s wealth management industry aiming to reduce the risk of accumulating across its financial system. The major reform is to shift to ‘traditional’ asset managers. China’s asset management industry was dominated by ‘quasi’ asset managers including bank wealth management products and trust companies whose nature is fundamentally different from global definitions. The traditional asset managers include mutual funds and private funds.
HNI needs include the likes of buying a property in Dubai, buying a structured product, picking up a stake in a promising or upcoming business, funding a real estate project through debt or could be even looking at the idea of buying into a distressed asset, or writing a complex will. 
Orange Business Services (France) and Additiv (Singapore), an expert in digital solutions for the financial market, have teamed up to offer digital wealth management service products. The cloud-based offerings will automate wealth management and address the strong growing demand for digital financial services from clients and the urgency to reduce operating costs by many financial institutions.
Due to constant increase in the number of high net-worth individuals all around the globe, this industry is expected to grow at an increasing rate in the coming years and shall see its roots expanding to regions of Africa, Latin America and Asia – Pacific.
To know more, click on the link below:
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204


Singapore Hospital Market Research Report-Ken Research


Research Methodology - Market Definitions
Hospital Market: The Singapore hospital market includes revenue generated by public and private hospitals established in Singapore. Revenue from outpatient and inpatient services has been considered. Revenues from public and private hospital has been tabulated in the market. Revenue from pharmacy retail though pharmacies located in hospitals has been included. Revenue stream such as lab revenues has also been considered. Revenue generated from walk-in patients for laboratory tests has not been considered. Hospitals with more than 50 beds have been considered.
Public Hospitals: Public health facilities refer to those owned or controlled by a government unit or another public corporation (where control is defined as the ability to determine the general corporate policy).

Not-for-profit hospitals: Not-for profit health facilities refer to those producing health goods and services, but are not permitted to be a source of income, profit or financial gain for the unit that establish, control or finance them.
Private Hospitals: Private health facilities refer to those set up for the purpose of producing health goods and services and are capable of generating a profit or other financial gains for their owners.
Acute Hospitals: Acute hospitals comprise both general hospitals and specialty centres (excluding Psychiatric Hospitals) with acute care inpatient and outpatient facilities.
Psychiatric Hospitals: Psychiatric hospitals are those hospitals which offer a comprehensive range of psychiatric, rehabilitative and counseling services in the field of mental health.
Community Hospitals: Community hospitals are those hospitals which cater to rehabilitation, geriatric care and coalescing patients. They are usually funded by charities or religious groups, with assistance from government funds and/or public healthcare professionals.

Research Methodology - Consolidated Research Approach
Hypothesis Creation: The research team has first framed a hypothesis about the market through analysis of existing industry factors obtained from magazines, journals, broker reports, investor presentations and annual reports of major companies and several articles. The team has used both public and proprietary databases to define and collect each market data point such as overall market size, segmentations and estimated future growth.
Hypothesis Testing: The research team conducted computer assisted telephonic interview (CATI) with several industry professionals including decision makers in hospitals. The industry professionals included several doctors, management executives, financial analysts and other higher level authorities. The analyst at Ken Research collated their insights on the market onboard and to seek justification to the hypothesis framed by the team. Additionally several clients from different hospitals in the ecosystem have been interviewed to understand their perspectives, needs, requirements and the prices charged for various medical services offered.

Sanity Checking @ Decision Tree Analysis: General consensus on data collected from primary research and public and proprietary databases has been reached by conducting in-house decision tree analysis of the data points available and by comparing it with macro-economic factors. Data has been collected and verified through cross-sanity checking between primary and secondary sources. Secondary data sources include the analysis of existing industry factors, obtained from company reports and from magazines, journals and online articles. The secondary data sources are used to form the initial perception and contention on several forces playing their role in determining the future growth in the industry.

Future Forecasting via Poll Opinions and Statistical Tools: Multi-Factor regression and scenario analysis was conducted on the lag variables i.e. on the historical market size of the industry by identifying the independent and quantifiable variables directly affecting the market. The forecasting was done by using SPSS statistical tools. The variables were checked for multi-co-linearity and other bias that could be present in the model. The conclusion from the regression was then double-checked by conducting poll opinions. Structured interviews were conducted through telecom with several industry veterans including major decision makers from. These interviews helped the research team to authenticate the data collected from secondary data sources and to reject or accept the hypothesis regarding the future projections.
Interpretation and Proofreading: The final analysis will then be interpreted in the research report by our expert team well versed with the Healthcare Market.

Research Methodology - Market Sizing and Limitation – Hospital Market
Market Sizing:
Initially, we have compiled a list of private and public hospitals on the basis of number of beds
Additionally, our team was able to get revenues from inpatients, outpatients and other revenue stream for certain hospitals, referring to our databases and also through accessing financial report of major hospitals. This helped us to understand average inpatient and outpatient charges on the basis of number of beds.
For the estimation of total hospital market, we have categorized the private and public hospital on the basis of number of beds and used average revenue per bed to estimate the market. We have also considered hospital revenue which comes from pharmacy and lab test as well.
Limitation:
The total number of beds in hospitals is not calculated by sum of the number of beds in each hospital. However, the number of beds in Singapore hospitals in fetched either from public database or from market players investor presentations.
Additionally, it can also happen that some hospitals might be witnessing higher amount of inpatient or outpatient due to their specialized services, but we have taken an average as it is difficult to get the financial and inpatients/outpatient data for each hospital.

Singapore Hospitals Market-Future Outlook and Projections, 2018-2022
Key Takeaway:
Adoption of telemedicine is another notable trend in this space. Further, medical apps providing virtual consultation. For instance, Doctor Anywhere App was launched in Singapore wherein the patients input the symptoms and the doctor consultation happens through video call. The MyDoc app, launched two years ago and targeted at businesses and insurance companies, lets users access doctors from various medical groups as well as pharmacists from Guardian. The company also conducts health screenings for small and medium-sized enterprises in Singapore. Both test results and follow-ups with doctors can be viewed and arranged within the app. The cost of MyDoc's services is pegged to individual insurance policies.
Since outpatient care is increasingly being used to deal with common medical issues in Singapore such applications and telemedicine services will enable patients to get accurate medical information at the convenience of home. Further with the growing burden of ageing population, hospitals are engaging robots and other assistive technology to ease the burden on the manpower-strapped sector. A robot can help recovering stroke patient’s exercise, keep early stage dementia patients occupied and alert them to take their medicine, or call for a helper when it senses that they are struggling to get up.
Automation of manual work, such as filling in medical information or ordering medications, is expected to allow healthcare professionals to focus on their core work, devoting more time to their clinical and direct patient care roles. Further, data analytics and artificial intelligence can augment care provided at each touch point. Mobile dental units and patient tracking devices are other new projects that tap on technology to improve Singapore’s healthcare productivity.

For more information on the research report, refer to below link:

Related Reports by Ken Research:



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Monday, July 2, 2018

Global Patent Ductus Arteriosus Market Outlook: Ken Research

Global Data’s clinical trial report, Patent Ductus Arteriosus Global Clinical Trials Review, H1, 2018" provides an overview of Patent Ductus Arteriosus clinical trials scenario. This report provides top line data relating to the clinical trials on Patent Ductus Arteriosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

To know more click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

RFID Technology in Logistics Market Outlook: Ken Research

Logistics and shipping industry analysis presents an ever increasing demand for technology that can make the handling process more efficient by saving time. A number of such developments have been made and many more are being experimented. Radio Frequency Identification or RFID is a data collection technology that uses electronic tags for storing data and is an automated form of identity verification.
Product identification is immensely important for smooth functioning and this sector has been upgraded with technologies such as Bar Code scanners. RFID is a method of storing data and retrieving it via radio waves much in the same way as a bar code can store information about the product. It uses electromagnetic fields to automatically identify and track tags attached to objects. The RFID tags contain electronically stored information and unique identifiers that correspond to inventory database records. Passive tags collect energy from a nearby RFID reader’s interrogating radio waves. Active tags have a local power source such as a battery and may operate hundreds of meters away from the RFID reader. RFID in logistics chain offers some significant advantages over traditional inventory control methods-
  1. RFID tags are superior to barcodes. Unlike a barcode the RFID tag need not be within the line of sight of the reader and may be embedded in the tracked object. Also, RFID tags hold more data than bar codes. A major differentiator is the unique serial number in the RFID’s Electronic Data Code (EPC) because it allows tracking of individual items. RFID works wirelessly, so you can point a scanner at a box of items and register each one without having to take them out first
  2. RFID tags contain a microchip hence, the transportation process will also be made smoother as RFID tags on shipping items are of small size and can easily be used, disposed and replaced after usage. This lets the controller know about transportation taking place.
  3. Safe and secure handling of goods is also made possible as tracking items is made easy and flexible with RFID. The storing and networking of information through RFID gives it an extra edge in security purposes as the tags can trigger security alarms if removed.
  4. RFID is able to scan multiple products simultaneously which is done without any human intervention making the process diligent. It therefore, acts as a responsible regulator of products.
  5. RFID can also be integrated with other systems and when scanned on entry and exit can let you know when the item left the premises.
Market research reports for logistics reveal that RFID, which is still in its developing stage, is attracting global interests. The RFID market is expected to hit a market value of USD 19 billion by 2026. The global RFID readers market is expected to witness a significant CAGR of 12.5% from 2017 to 2027.
RFID is widely being promoted as a step forward in logistics management with its advanced techniques. The various uses of RFID tags are still being explored and its ability to track items is gaining popularity among automobile manufacturers, pharmaceutical companies and for livestock management despite the related privacy concerns owing to its ability to get attached and read personally linked information without consent.
Key Factors Considered in the Report:
Logistics and Shipping Market Research Reports
Logistics and Shipping Industry Analysis
Market Research Reports for Logistics
Logistic Market Research Report
Logistics and Transportation Market Research Reports Consulting
Logistics Business Review
Logistics and Shipping Industry Research and Market Reports
To know more, click on the link below:
Contact Us:
Ken Research 
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Advancements In Stem Cell Research Market Outlook-Ken Research


Advancements in medicine have led us to a time where there are options available to regenerate organs. Stem cell surgery is the use of stem cells to treat ailments and is gaining popularity for its ability to regenerate body tissue. Healthcare market research report consulting shows that it already has wide ranged uses in orthopedics, blood cell formation and brain and spinal cord injuries. Its application on the heart is also being extensively researched. Heart failure occurs when the heart does not pump sufficient blood to maintain bodily functions.

Heart Failure is a chronic disease needing lifelong management however, with treatment signs and symptoms can improve even making the heart stronger sometimes thereby helping you live longer and reducing your chance of dying suddenly. Doctors can sometimes correct heart failure by treating the underlying cause for example repairing a heart valve or controlling a fast heart rhythm may reverse heart failure. For most people though, treatment of heart failure involves a balance of the right medications and in some cases use of devices that help the heart beat and contract properly. Now a new research is being carried out to augment the use of stem cells in the process of treatment.  Clinical trial planning is underway at US based MedStar Heart & Vascular Institute to determine whether novel stem cell therapy will improve heart function for patients with heart failure. The trial will use CardioCell’s proprietary Mesenchymal Stem Cells (MSCs) manufactured by Stemedica. The goal is to improve outcomes in patients with heart failure and left ventricular assist devices (LVADs).

This research is a leap forward not only from the medical science perspective but also from a business standpoint. Healthcare business review indicates that the global stem cell market is expected to reach nearly USD 16 billion by 2025 growing at a CAGR of 9.4% approximately. This research has led to the partnership of three highly reputed US based institutions.  MedStar Heart & Vascular Institute is a national leader in research, diagnosis and treatment of cardiovascular disease and has been consistently ranked as one of the premier destinations for cardiac care in the region for more than 55 years. Stemedica Cell Technologies is a global leader in regenerative medicine that develops, manufactures and distributes adult allogeneic stem cell products and   houses more than 30 years of research and innovation. CardioCell is a global biotechnology company that explores therapeutic applications of stem cells and has an exclusive worldwide license from Stemedica Cell Technologies for the exploration of therapeutic cardiovascular indications including Chronic Heart Failure (CHF).

This research also proves that stem cells are gaining global interests. Stem cells are being used as building blocks for humans that are not only benefiting medical science by increasing its scope but also paving the way for further research and discoveries. Big medical companies are actively investing in the bright future of stem cells and this is evident by the research project being carried out by MedStar Heart & Vascular Institute. Technologically advanced countries are constantly attempting to increase the utility from stem cell products which is the main growth driver with the US being at the forefront of this movement.

To know more, click on the link below:

Related Report:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Global Pathological Gambling Market Research Report: Ken Research

Global Data’s clinical trial report, Pathological Gambling Global Clinical Trials Review, H1, 2018" provides an overview of Pathological Gambling clinical trials scenario. This report provides top line data relating to the clinical trials on Pathological Gambling. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

To know more click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Increasing Opportunity in Indian Real Estate Market Outlook: Ken Research

India has been investing in many sectors to further its economic performance. One such sector is the real estate sector in which the huge population is seen as a growth driver. Recent years have seen many new developments in technology and trade with foreign investors increasing their interest in India. There have also been a number of significant policy changes and the effects of the imposition of such laws are currently debatable. However, real estate industry research and market reports suggest that 2018 will be a favorable year for the Indian real estate market which will benefit from recent reforms.
Real estate market research reports bring out the fact that in 2018 there are several challenges and opportunities for growth especially for the home buyers and home developers. All this comes after a very irregular movement of the industry in 2017 when too many things happened. The effect of demonetization was still visible in 2017. The Central   Government in the Union Budget 2017-18 introduced ‘Housing for All by 2022’ which comes with a number of benefits like availability of prime land parcels, access to funds and fast approval of incentivizing for the affordable housing projects. The government also introduced RERA to bring complete transparency between buyers and sellers. This act has raised the interests of home buyers and confidence among the consumers. Furthermore, the introduction of GST in 2017 aimed to dismantle multiple tax system and the effects were evident as in 2017, 30% less units got sold out compared to 2016.
For 2018 there is some expectation from both buyers and developers that new government policies will boost the housing sector. India is working on promoting Real Estate Investment Trust (REIT) and there is also projection of receiving Private Equity (PE) investment of about USD 4 billion during the fiscal year. As far as listing down the metro city that would yield a good return to developers, Bangalore tops the list.
RERA though good for the public, presents a very different scenario to the developers. They have to face the restriction to new construction and instead complete the existing ones within the deadline. As a result 2018 is expected to witness major sales and delivery in the residential market.
Since the establishment of GST the real estate sector has been facing huge roadblocks due to high GST rates. The government needs to realize that home buying is a huge investment and such unfavorable tax conditions are detrimental to the industry. Estimates show that the government should bring down the GST rate 6% to encourage buyers to invest in new projects. However, the government has taken a few steps to change the scenario. These include various tax incentives and reforms like interest subsidy.
Input costs are also on the rise. Since real estate is a capital and labour intensive industry, a rise in the cost of labour will create issues. Cement companies have also raised prices creating problems in project development. The government is trying to compensate by launching schemes like Pradhan Mantri Awas Yojana which aims to build houses for everyone by 2022.
Major developments have affected Indian real estate recently. The government has attempted to maintain a healthy environment for everyone by launching schemes and subsidies. It has also aimed to increase transparency in the market by furthering RERA which promotes clean capital. Such steps that incorporate favorable government schemes, FDI and transparency are expected to drastically change the future of the real estate sector in India starting from 2018. 
Key Topics Covered in the Report
Real Estate Market Research Reports
Real Estate Industry Analysis
Market Research Reports for Real Estate
Real Estate Industry Research Report
Real Estate Market Research Reports Consulting
Real Estate Business Review
Real Estate Industry Research and Market Reports
For more information on the research report, refer to below link:
Contact:          
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204